<i>ALK</i> Deletion Exons 2 to 19: Case Report of a Rare ALK Inhibitor-Responsive Lung Cancer Driver Oncogene.

ALK Deletion Exons 2 to 19: Case Report of a Rare ALK Inhibitor-Responsive Lung Cancer Driver Oncogene.

Schoepflin, Zachary R; Academia, Emmeline; Osataphan, Soravis A; Rangachari, Deepa; Sharifi, Sheida; VanderLaan, Paul A; Costa, Daniel B.

Afiliação

Schoepflin ZR; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Academia E; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Osataphan SA; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Rangachari D; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Sharifi S; Department of Pathology, Lahey Hospital and Medical Center, Burlington, Massachusetts.
VanderLaan PA; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Costa DB; Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

JTO Clin Res Rep ; 4(4): 100489, 2023 Apr.

Article em En | MEDLINE | ID: mdl-36994308